SMO Clinplus Co (SZSE:301257) Common Stock : ¥61.2 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Common Stock?

SMO Clinplus Co's quarterly common stock stayed the same from Sep. 2023 (¥61.2 Mil) to Dec. 2023 (¥61.2 Mil) and stayed the same from Dec. 2023 (¥61.2 Mil) to Mar. 2024 (¥61.2 Mil).

SMO Clinplus Co's annual common stock increased from Dec. 2021 (¥45.0 Mil) to Dec. 2022 (¥61.0 Mil) and increased from Dec. 2022 (¥61.0 Mil) to Dec. 2023 (¥61.2 Mil).

SMO Clinplus Co Common Stock Historical Data

The historical data trend for SMO Clinplus Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Common Stock Chart

SMO Clinplus Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

45.00

60.98

61.16

SMO Clinplus Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															60.98	60.98	61.16	61.16	61.16

SMO Clinplus Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

SMO Clinplus Co (SZSE:301257) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001

Website

http://www.smo-clinplus.com

SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.

Executives

Lai Chun Bao	Director
Ma Lin	Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines